Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gene Mack currently holds 200,000 shares of Gain Therapeutics, Inc. (GANX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gene Mack has been a net buyer of GANX stock. They have purchased $14.5K and sold $0 worth of shares.
Gene Mack's most recent insider trade was on Mar 24, 2026, when they sold 200,000 shares at $0.00 per share.
Gene Mack serves as Executive at Gain Therapeutics, Inc. (GANX). They have executed 3 insider transactions totaling $14.5K over their tenure at the company.
Gene Mack holds the position of Executive at Gain Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Gene Mack has shown a buying trading pattern, with $14.5K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Gene Mack was on Aug 9, 2024, when they purchased $14.5K worth of GANX shares. This transaction involved 14,400 shares at $1.01 per share.
Gene Mack currently owns 200,000 shares of Gain Therapeutics, Inc. (GANX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gene Mack's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gene Mack has 3 Form 4 filings on record as an insider at Gain Therapeutics, Inc..
Set alerts for Gene Mack and 40,000+ other insiders.